12 Health Care Stocks Moving In Thursday's After-Market Session
GainersVaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday's after-market session. The market value of their outstanding shares is at $327.1 million. Venus Concept (NASDAQ:VERO) s
Express News | Conduit Pharmaceuticals Set To Join Russell 3000 Index At Market Open On July 1, 2024
Express News | Presidio Property Trust Announces Conduit Pharmaceuticals To Be Added To Russell 2000 Index Effective July 1, 2024; Presidio Owns 6.3% Of Conduit
A Presidio Property Trust Major Investment To Be Part of Russell 2000
SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (NASDAQ:SQFT, SQFTP, SQFTW)) ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), has
10-Q: Quarterly report
Express News | Conduit Pharmaceuticals-on April 11,Determined Financial Statements for 3 Months Ended March,June, Sept 2023 Should No Longer Be Relied Upon
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall On AI Says It Is A Double-Edge Sword; AI Is Going To Help Say What Drug May Have An Effect; We Might Be Able To Test Connections And Validate More Quickly; Moves Treatments To Patients Faster
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall On Technology In Healthcare Says With Progress In Technology And Way We Use It, Imagine Gaps Filled In Rural Environment; Right Data Predict What Patients Are Becoming More Ill
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says Attention Turned Again From A Scientific Standpoint If We Can Apply Ourselves
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says Make Sure Message Gets Out And Data That Backs This Up Is There
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says Health Is A Pivot For Almost Everything We Want To Accomplish As Individuals, Communities And As A Country; Data Suggests That Country's Health Is Good Wealth Is Good
From Benzinga's Healthcare Summit Freda Lewis-Hall Says We Have A Whole Host Of Things To Address If We Want Equity
From Benzinga's Healthcare Summit Freda Lewis-Hall Says We Have A Whole Host Of Things To Address If We Want Equity
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says We're Reimaging Power Of Data And Analytics; I Like Paying Close Attention to Companies, Organizations, Institutions And Individuals That Are Doing Work To Turbocharge Us With Data That Are Helping W
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says Events Of Last Few Years May Help With COVID And World Events; COVID Brought Some Heat To Evolving Our Healthcare System
Express News | From Benzinga's Healthcare Summit Freda Lewis-Hall Says Model Of Working In Autoimminuty Has Changed A Little Bit; With COVID-19 We Discovered It Was Your Immune Systems Reactions To The Virus That Killed You
Express News | From Benzinga's Healthcare Summit Senior Vice President, Equity Research At Wedbush Securities Laura Chico, PhD. Says Within Biotech You're Taking Different Kind Of Risk Bets With Respect To Kind Of Developmental Therapies Not Yet At The Market Stage; Spe
Express News | From Benzinga's Healthcare Summit Senior Vice President, Equity Research At Wedbush Securities Laura Chico, PhD. On Innovation Says RNA Targeted Therapies Are Pretty Exciting; Oncology Always Big And Biotech; Number Of Companies We Follow In Epilepsy Spac
Express News | From Benzinga's Healthcare Summit Senior Vice President, Equity Research At Wedbush Securities Laura Chico, PhD. Says Large Cap Pharma, Biotech Are Still In Need Of New Assets And Should Try To Work Those Revenue Projections Higher
Express News | From Benzinga's Healthcare Summit Senior Vice President, Equity Research At Wedbush Securities Laura Chico, PhD. Says I Think Biotech M&A Has Been Pretty Elevated Compared To Prior Periods; First And Fourth Quarters Typically Hot Periods; Past Couple Mont
Express News | From Benzinga's Healthcare Summit Senior Vice President, Equity Research At Wedbush Securities Laura Chico, PhD. Says More Of An Upswing On The IPO Front
No Data